Bone remodeling in the Masquelet-induced membrane model of rat femur by modulation of H-type vessels by total flavonoids of rhizome drynariae

doi:10.12307/2024.502

Abstract

Abstract: BACKGROUND: Several studies have found that the total flavonoids of rhizome drynariae can promote neovascularization in the induced membrane, improve the biological properties of the induced membrane, and accelerate bone remodeling in the induced membrane, but the related molecular mechanisms still need to be further explored.
OBJECTIVE: To explore the effect of total flavonoids of rhizome drynariae on bone remodeling in rat femoral Masquelet-induced membrane model by regulating H-type blood vessels.
METHODS: Thirty-six male Sprague-Dawley rats were stratified by body mass and then randomly divided into blank group, model group and traditional Chinese medicine group, with 12 rats in each group. A 4-mm femoral bone defect model was established in all the rats. Bone defects in the model group and traditional Chinese medicine group were filled with polymethylmethacrylate bone cement. At 6 weeks after modeling, the tail bone of the rats was implanted in the blank group, as well as in the other two groups after removal of bone cement. The traditional Chinese medicine group was given 157.5 mg/kg per day of total flavonoids of rhizome drynariae at 3 days after bone implantation, while the model and blank groups were given the same amount of saline by gavage until the 8th week after bone implantation. Bone graft samples were taken for relevant testing at 8 weeks after implantation.
RESULTS AND CONCLUSION: X-ray films showed that in the blank group, the fracture line in the defect area was clear, and only a small amount of bone callus formed; in the model group, the bone defect area still existed, where discontinuous cortical bone was visible; in the traditional Chinese medicine group, the defect area was filled with newborn bone tissues, the bone marrow cavity and part of the cortical bone formed, and the fracture line disappeared. Micro-CT scans showed that the amount of new bone in the defect area was low in the blank group, the number of bone trabeculae in the defect area was significantly increased in the model group, and a large amount of new bone tissue was filled in the bone defect area in the traditional Chinese medicine group. Hematoxylin-eosin staining results showed that in the blank group, only a small amount of new bone formed in the defect area and the quality of osteogenesis was poor; in the model group, there was more new bone tissue in the defect area, but some fibrous connective tissues were interspersed within the bone tissue; and in the traditional Chinese medicine group, a large amount of new bone formed in the defect area and the quality of osteogenesis was the best. CD31/Emcn immunofluorescence double-labeling staining results showed that the number of H-type blood vessels in the newborn bone tissue in the bone defect area of the blank group was sparse and sparsely distributed; compared with the blank group, there were more H-type blood vessels in the bone tissue in the bone defect area of the model group, and the blood vessels were distributed in relatively regular strips; the number of H-type blood vessels in the bone defect area of the traditional Chinese medicine group was the highest and the blood vessels were densely distributed. To conclude, the total flavonoids of rhizoma drynariae can upregulate the expression of H-type blood vessels to enhance the angiogenic-osteogenic effect, improve the osteogenic efficiency of the rat femoral Masquelet induced membrane model, and promote bone remodeling.

Key words: Masquelet technique, total flavonoids of rhizome drynariae, H-type vessel, induced membrane, bone defect, bone remodeling

CLC Number:

Zeng Zhikui, Xiong Wei, Liang Weidong, Qian Guowen, Liang Chaoyi, Pan Bin, Guo Ling, Wei Wenqiang, Qiu Xunxiang, Deng Wenfang, Yuan Lingmei. Bone remodeling in the Masquelet-induced membrane model of rat femur by modulation of H-type vessels by total flavonoids of rhizome drynariae[J]. Chinese Journal of Tissue Engineering Research, 2024, 28(32): 5130-5135.

Figures/Tables 7

References

[1] NORRIS BL, VANDERKARR M, SPARKS C, et al. Treatments, cost and healthcare utilization of patients with segmental bone defects. Injury. 2021;52(10):2935-2940.
[2] BALL AN, DONAHUE SW, WOJDA SJ, et al. The challenges of promoting osteogenesis in segmental bone defects and osteoporosis. J Orthop Res. 2018;36(6):1559-1572.
[3] MIGLIORINI F, MAFFULLI N, BARONCINI A, et al. Allograft Versus Autograft Osteochondral Transplant for Chondral Defects of the Talus: Systematic Review and Meta-analysis. Am J Sports Med. 2022;50(12): 3447-3455.
[4] MATIĆ S, VUČKOVIĆ Č, LEŠIĆ A, et al. Pedicled vascularized bone grafts compared with xenografts in the treatment of scaphoid nonunion. Int Orthop. 2021;45(4):1017-1023.
[5] YANG N, MA T, LIU L, et al. Shortening/re-lengthening and nailing versus bone transport for the treatment of segmental femoral bone defects. Sci Rep. 2023;13(1):13288.
[6] LENZE U, O SULLIVAN M, MCCOMBE D, et al. Intramedullary Fixation of Double-Barrel Vascularised Fibula Grafts With Subsequent Lengthening for Reconstruction of the Distal Femur in Patients With Osteosarcoma. J Orthop. 2022;42(6):e674-e681.
[7] DAHL MT, MORRISON S. Segmental Bone Defects and the History of Bone Transport. J Orthop. Trauma. 2021;35(4): S1-S7.
[8] OLIVA F, MIGLIORINI F, CUOZZO F, et al. Outcomes and complications of the reamer irrigator aspirator versus traditional iliac crest bone graft harvesting: a systematic review and meta-analysis. J Orthop Traumatol. 2021;22(1):50.
[9] MASQUELET AC, FITOUSSI F, BEGUE T, et al.Reconstruction of the long bones by the induced membrane and spongy autograft. Ann Chir Plast Esthet. 2000;45(3):346-353.
[10] DIOMEDE F, MARCONI GD, FONTICOLI L, et al. Functional Relationship between Osteogenesis and Angiogenesis in Tissue Regeneration. Int J Mol Sci. 2020;21(9):3242.
[11] KUSUMBE AP, RAMASAMY SK, ADAMS RH. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature. 2014; 507(7492):323-328.
[12] PENG Y, WU S, LI Y, et al. Type H blood vessels in bone modeling and remodeling. Theranostics. 2020;10(1):426-436.
[13] ZHANG J, PAN J, JING W. Motivating role of type H vessels in bone regeneration. Cell Prolif. 2020;53(9):e12874.
[14] 申震,陈泽华,郭英,等.骨碎补总黄酮对牵张成骨模型大鼠中H血管及成血管-成骨耦联的作用[J].中华中医药杂志,2022,37(3): 1352-1356.
[15] 黄敏玲,卢赵琦,申震,等.骨碎补总黄酮干预Notch信号通路影响骨重建过程中成血管-成骨耦联[J]. 中国组织工程研究,2021, 25(32):5116-5122.
[16] 曾志奎,黄枫,李悦,等.骨碎补总黄酮对大鼠Masquelet诱导膜血管新生因子表达的影响[J].中华中医药学刊,2019,37(10): 2345-2348.
[17] 曾志奎,黄枫,黄培镇,等.大鼠股骨Masquelet诱导膜实验模型的建立[J].山东医药,2017,57(48):1-4.
[18] LANE JM, SANDHU HS. Current approaches to experimental bone grafting. Orthop Clin North Am. 1987;18(2):213-225.
[19] WANG L, YOU X, ZHANG L, et al. Mechanical regulation of bone remodeling. Bone Res. 2022;10(1):16.
[20] GROSSO A, BURGER MG, LUNGER A, et al. It Takes Two to Tango: Coupling of Angiogenesis and Osteogenesis for Bone Regeneration. Front Bioeng Biotechnol. 2017;5:68.
[21] SCHIPANI E, MAES C, CARMELIET G, et al. Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF. J Bone Miner Res. 2009;24: 1347-1353.
[22] IGNATIUS A, TUCKERMANN J. New horizons for osteoanabolic treatment? Nat Rev Endocrinol. 2018;14(9):508-509.
[23] 黄敏玲,卢赵琦,申震,等.骨碎补总黄酮干预Notch信号通路影响骨重建过程中成血管-成骨耦联[J]. 中国组织工程研究,2021, 25(32):5116-5122.
[24] XU R, YALLOWITZ A, QIN A, et al. Targeting skeletal endothelium to ameliorate bone loss. Nat Med. 2018;24(6): 823-833.
[25] XIE H, CUI Z, WANG L, et al. PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat Med. 2014;20(11):1270-1278.
[26] PENG Y, WU S, LI Y, et al. Type H blood vessels in bone modeling and remodeling. Theranostics. 2020;10(1):426-436.
[27] ALFORD AI, NICOLAOU D, HAKE M, et al. Masquelet’s induced membrane technique: Review of current concepts and future directions. J Orthop Res. 2021;39(4):707-718.
[28] 连霄,顾晓民,孙洪军,等.植骨后外固定支架固定联合健骨促愈中药治疗胫骨骨折不愈合的临床研究[J].中华中医药学刊,2017, 35(10):2643-2645.
[29] 傅淑平,杨丽,龚理,等.梓醇促大鼠骨髓间充质干细胞骨向分化的机制研究[J].中国病理生理杂志,2019,35(5):907-913.
[30] 熊伟,袁灵梅,钱国文,等.“补肾壮骨”中药应用于骨组织工程支架修复节段性骨缺损[J].中国组织工程研究,2023,27(21):3438-3444.
[31] 陈桂锋,尚奇,沈耿杨,等.从“肾主骨生髓”揭示骨质疏松症炎症微环境的中医理论基础[J].中华中医药杂志,2022,37(12):6906-6909.
[32] 李建国,谢兴文,李鼎鹏,等.从BMSCs探讨“肾主骨生髓”理论指导下中医药治疗骨质疏松症的研究[J].中国骨质疏松杂志, 2022,28(8):1205-1207,1218.
[33] LI S, ZHOU H, HU C, et al. Corrigendum: Total Flavonoids of Rhizoma Drynariae Promotes Differentiation of Osteoblasts and Growth of Bone Graft in Induced Membrane Partly by Activating Wnt/beta-Catenin Signaling Pathway. Front Pharmacol. 2021;12:726831.